Immunodominant Stress Proteins of Porphyromonas gingivalis

牙龈卟啉单胞菌的免疫显性应激蛋白

基本信息

  • 批准号:
    7523092
  • 负责人:
  • 金额:
    $ 39.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-04-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chaperones or heat shock proteins are found in all cells from bacteria to man and are among the most highly conserved and immunodominant molecules in nature. Originally thought to facilitate the three dimensional assembly of proteins it has become increasingly clear that these molecules have functions involving the immune response to a variety of microorganisms. In addition it has been shown that protective response to stress proteins may be involved in control of diseases like IBD, Legionella, Yersinia, Chlamydia and H. pylori infections and arteriosclerosis. The long-term goals of this work is to deliniate the mechanisms of chaperone involvement in periodontitis and periodontitis-related systemic disease and to develop strategies for medicinal treatment for those diseases. We have shown that elevated levels of antibodies to the HSP90 homolog (HtpG) of the periodontal pathogen P. gingivalis were found associated with better oral health in a group of gingivitis subjects. During our current grant we have demonstrated HtpG has the ability to induce immunomodulatory activity similar to chaperones from other bacteria associated with chronic infectious diseases. In periodontitis P. gingivalis HtpG recruits antibody producing cells to the lesion and upregulates chemokine receptors on both leukocytes and vascular cells contributing to the continuning tissue destruction. HtpG is found in circulation and CVD atheromas and can induce foam cell formation, an important step in atherosclerotic plaque formation. Antibodies to HtpG downregulate IL-8 production in both leukocytes and vein cells and may mitigate the inflammatory effects in periodontitis. This application will 1) chacterize the distinct receptor-mediated immunomodulatory activities of P. gingivalis HtpG in vitro; 2) demonstrate the same activity in vivo in periodontitis and vascular tissue by microdisection, genomic/proteomic approaches; 3) correlate serum antibodies to the presence of the molecules that drive this process. Such a demonstration will prepare the way for novel therapeutic and diagnostic modalities for both periodontitis and periodontitisrelated systemic diseases. PROJECT NARATIVE: Molecules that produce a particular class of proteins proteins in cells called chaperones can become involved in disease processes under some circumstances. Understanding the way this happens can lead to treatments for chronic diseases that are the result of long-lasting, unresolved periodontitis.
描述(由申请人提供):伴侣蛋白或热休克蛋白存在于从细菌到人类的所有细胞中,并且是自然界中最高度保守和免疫显性的分子之一。最初被认为促进蛋白质的三维组装,但越来越清楚的是,这些分子具有涉及对多种微生物的免疫反应的功能。此外,研究表明,对应激蛋白的保护性反应可能参与控制炎症性肠病、军团菌、耶尔森氏菌、衣原体和幽门螺杆菌感染以及动脉硬化等疾病。这项工作的长期目标是阐明伴侣参与牙周炎和牙周炎相关全身性疾病的机制,并制定针对这些疾病的药物治疗策略。我们发现,在一组牙龈炎受试者中,牙周病原体牙龈卟啉单胞菌的 HSP90 同源物 (HtpG) 抗体水平升高与更好的口腔健康相关。在我们目前的资助期间,我们已经证明 HtpG 具有诱导免疫调节活性的能力,类似于其他与慢性传染病相关的细菌的伴侣。在牙周炎中,牙龈卟啉单胞菌 HtpG 将产生抗体的细胞募集到病变部位,并上调白细胞和血管细胞上的趋化因子受体,从而导致持续的组织破坏。 HtpG 存在于循环系统和 CVD 粥样斑块中,可诱导泡沫细胞形成,这是动脉粥样硬化斑块形成的重要步骤。 HtpG 抗体可下调白细胞和静脉细胞中 IL-8 的产生,并可能减轻牙周炎的炎症作用。该应用将 1) 表征 P. gingivalis HtpG 体外独特的受体介导的免疫调节活性; 2) 通过显微切割、基因组/蛋白质组学方法证明在牙周炎和血管组织中具有相同的体内活性; 3) 将血清抗体与驱动该过程的分子的存在相关联。这样的示范将为牙周炎和牙周炎相关全身性疾病的新治疗和诊断方式铺平道路。 项目叙述:在细胞中产生特定类别蛋白质(称为伴侣蛋白)的分子在某些情况下可能参与疾病过程。了解这种情况发生的方式可以帮助治疗由长期未解决的牙周炎引起的慢性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENNIS E LOPATIN其他文献

DENNIS E LOPATIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENNIS E LOPATIN', 18)}}的其他基金

SALIVARY FACTORS AND DENTAL/MEDICAL RISK FACTORS
唾液因素和牙科/医疗风险因素
  • 批准号:
    6296265
  • 财政年份:
    1999
  • 资助金额:
    $ 39.89万
  • 项目类别:
SALIVARY FACTORS AND DENTAL/MEDICAL RISK FACTORS
唾液因素和牙科/医疗风险因素
  • 批准号:
    6104771
  • 财政年份:
    1999
  • 资助金额:
    $ 39.89万
  • 项目类别:
SALIVARY FACTORS AND DENTAL/MEDICAL RISK FACTORS
唾液因素和牙科/医疗风险因素
  • 批准号:
    6296270
  • 财政年份:
    1998
  • 资助金额:
    $ 39.89万
  • 项目类别:
SALIVARY FACTORS AND DENTAL/MEDICAL RISK FACTORS
唾液因素和牙科/医疗风险因素
  • 批准号:
    6270308
  • 财政年份:
    1998
  • 资助金额:
    $ 39.89万
  • 项目类别:
SALIVARY FACTORS AND DENTAL/MEDICAL RISK FACTORS
唾液因素和牙科/医疗风险因素
  • 批准号:
    6238442
  • 财政年份:
    1997
  • 资助金额:
    $ 39.89万
  • 项目类别:
IMMUNODOMINANT STRESS PROTEINS OF P GINGIVALIS
牙龈卟啉单胞菌的免疫显性应激蛋白
  • 批准号:
    2132234
  • 财政年份:
    1996
  • 资助金额:
    $ 39.89万
  • 项目类别:
Immunodominant Stress Proteins of Porphyromonas gingivalis
牙龈卟啉单胞菌的免疫显性应激蛋白
  • 批准号:
    7826763
  • 财政年份:
    1996
  • 资助金额:
    $ 39.89万
  • 项目类别:
IMMUNODOMINANT STRESS PROTEINS OF P. GINGIVALIS
牙龈卟啉单胞菌的免疫显性应激蛋白
  • 批准号:
    6634634
  • 财政年份:
    1996
  • 资助金额:
    $ 39.89万
  • 项目类别:
IMMUNODOMINANT STRESS PROTEINS OF P. GINGIVALIS
牙龈卟啉单胞菌的免疫显性应激蛋白
  • 批准号:
    6516473
  • 财政年份:
    1996
  • 资助金额:
    $ 39.89万
  • 项目类别:
IMMUNODOMINANT STRESS PROTEINS OF P. GINGIVALIS
牙龈卟啉单胞菌的免疫显性应激蛋白
  • 批准号:
    6900249
  • 财政年份:
    1996
  • 资助金额:
    $ 39.89万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 39.89万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 39.89万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 39.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了